Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Nov 21, 2012

PerkinElmer Establishes Presence in Southern Africa

  • PerkinElmer has opened direct operations in Midrand, South Africa. The new headquarters will support the company’s business across all Southern African countries in academia, mining and mineral testing, chemical and petrochemical analysis, pharmaceutical applications, and food and beverage safety testing.

     “Southern Africa represents a critical region for PerkinElmer and is an integral component of our growth and geographic expansion strategy,” said Lapo Paladini, chief marketing officer, PerkinElmer. “The opening of our new headquarters will bring our knowledge and expertise as well as our innovative solutions directly to Southern Africa in order to support the fast growing local economy while helping customers advance human and environmental health in the region.”

     The new Southern Africa headquarters will be equipped with a Customer Knowledge Center which will serve as a demonstration, application support and service center. The facility will have responsibility for the company’s analytical sciences and laboratory services offerings.

     PerkinElmer will be among other biotech companies in Southern African, including Biotech Laboratories which is also located in Midrand.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »